Aveanna Healthcare Boosted by Strong Q2 Results and Revised 2025 Outlook

Aveanna Healthcare shares are trading higher after the company reported a 16.8% revenue increase and 93.6% EBITDA growth for Q2 2025, alongside a positive revised outlook.